Azul (NYSE:AZUL – Get Free Report) saw a significant growth in short interest in the month of August. As of August 31st, there was short interest totaling 78,731 shares, a growth of 125.6% from the August 15th total of 34,906 shares. Based on an average trading volume of 148,945 shares, the short-interest ratio is presently 0.5 days. Approximately 0.0% of the shares of the company are short sold.
Wall Street Analyst Weigh In
AZUL has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft started coverage on Azul in a report on Wednesday, September 9th. They set a “buy” rating and a $11.00 price target for the company. Wall Street Zen cut Azul from a “hold” rating to a “sell” rating in a research report on Tuesday, September 8th. Zacks Research raised shares of Azul to a “strong sell” rating in a report on Wednesday, July 22nd. Weiss Ratings started coverage on Azul in a report on Friday, July 10th. They issued a “sell (d)” rating for the company. Finally, BWS Financial reaffirmed a “buy” rating and set a $20.00 price objective on shares of Azul in a report on Monday, August 17th. Two analysts have rated the stock with a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $15.50.
View Our Latest Analysis on AZUL
Azul Price Performance
Azul Company Profile
Azul SA is a Brazilian airline that provides scheduled passenger air transportation and related services. Founded in 2008 by entrepreneur David Neeleman, the company was established to expand air connectivity in Brazil, including service to cities that have historically had limited access to commercial aviation.
Azul operates domestic flights throughout Brazil and serves selected international destinations in North and South America and Europe. Its operations include passenger travel, air cargo through Azul Cargo Express, and vacation and travel packages offered through Azul Viagens.
Further Reading
- Five stocks we like better than Azul
- 3 Healthcare Stocks for 3 Stages of Life
- Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
- MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky
- Cashing in on the Qubit: NVIDIA Takes the Quantum Leap
Receive News & Ratings for Azul Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azul and related companies with MarketBeat.com's FREE daily email newsletter.
